Vaccinations against mpox in Congo will begin next month, authorities say
Authorities say a vaccination campaign against mpox in Congo will begin Oct. 2, with workers focusing on the three most affected provinces first
Vaccinations against mpox in Congo will begin next month, authorities say
Show all 3Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.A vaccination campaign against mpox in Congo will begin Oct. 2, authorities said Saturday, with workers focusing on the three most affected provinces first.
Adults in Equateur, South Kivu and Sankuru provinces will be vaccinated first, Cris Kacita Osako, coordinator of Congo’s Monkeypox Response Committee, told The Associated Press.
Earlier this week, the first batch of mpox vaccines arrived in the capital of Congo, the center of the outbreak. The 100,000 doses of the JYNNEOS vaccine, manufactured by the Danish company Bavarian Nordic, were donated by the European Union through HERA, the bloc’s agency for health emergencies. Another 100,000 were delivered on Saturday.
The 200,000 doses are just a fraction of the 3 million doses authorities have said are needed to end the mpox outbreaks in Congo, the epicenter of the global health emergency. The European Union countries pledged to donate more than 500,000 others, but the timeline for their delivery remained unclear.
Since the start of 2024, there have been 5,549 confirmed mpox cases across the continent, with 643 associated deaths, representing a sharp escalation in both infections and fatalities compared to previous years. The cases in Congo constituted 91% of the total number. Most mpox infections in Congo and Burundi, the second most affected country, are in children under age 15.
On Friday, the Africa Center for Disease Control and Prevention and the World Health Organization launched a continent-wide response plan to the outbreak of mpox, three weeks after WHO declared outbreaks in 12 African countries a global emergency.
Congo issued an emergency approval of the vaccine, which has already been used in Europe and the United States in adults. For the moment, the rollout will be reserved for adults, with priority targeted groups being those who have been in close contact with infected people and sex workers, the Africa Center for Disease Control and Prevention Director-General Dr. Jean Kaseya told reporters on Friday.
The European Medicines Agency is examining additional data to be able to administer it to children ranging in age from 12 to 17, which could happen at the end of the month, HERA Director-General Laurent Muschel said.
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.